An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App
Launched by COCHLEAR · Oct 19, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to test a new mobile app that helps measure how well adults with cochlear implants can understand speech. Cochlear implants are devices that can improve hearing for people with significant hearing loss. The goal is to see if this app can accurately assess speech perception, which is how well a person can understand spoken words.
To participate, you need to be an adult aged 18 or older who uses a hearing device, such as a hearing aid or cochlear implant, and you should be fluent in the language used during the study. Participants will be asked to use the app multiple times to provide feedback on their speech understanding. The study is currently recruiting, so if you meet the criteria and are interested, you could contribute to important research that may help improve hearing assessments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults 18 years of age or older.
- • Uses a hearing device or devices (hearing aid/s and/or cochlear implant/s).
- • Fluent speaker in the language used to assess clinical performance as judged by the investigator.
- • Willing and able to provide written informed consent.
- Exclusion Criteria:
- • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator.
- • Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.
- • Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation.
- • Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device (unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation).
- • Women who are pregnant.
About Cochlear
Cochlear Limited is a global leader in implantable hearing solutions, dedicated to transforming the lives of individuals with hearing loss through innovative technology and comprehensive clinical research. With a strong commitment to advancing auditory rehabilitation, Cochlear conducts rigorous clinical trials aimed at evaluating the safety and efficacy of its products, including cochlear implants and bone conduction devices. The company collaborates with healthcare professionals and research institutions worldwide to ensure that its solutions meet the highest standards of quality and performance, ultimately enhancing patient outcomes and promoting accessibility to hearing health care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lone Tree, Colorado, United States
Melbourne, Victoria, Australia
Wommelgem, Antwerp, Belgium
Antwerp, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported